Nov 11 (Reuters) - GSK plc:
* GSK PLC - GSK UPDATE: ZEJULA 2L IN US
* GSK PLC - GSK UPDATE: ZEJULA 2L IN US
* GSK: AT REQUEST OF FDA WILL RESTRICT SECOND-LINE MAINTENANCE INDICATION FOR ZEJULA TO ONLY PATIENTS WITH DELETERIOUS OR SUSPECTED DELETERIOUS GERMLINE BRCA MUTATIONS Source text for Eikon: Further company coverage: